Skip to main content

Table 1 Thromboelastometry and platelet function analyses in undiluted blood samples and samples diluted with 0.9 % saline, 3 % hypertonic saline, and 20 % mannitol in a ratio of 1:16 and 1:8 in 15 dogs

From: In vitro effects of 3 % hypertonic saline and 20 % mannitol on canine whole blood coagulation and platelet function

Variable

Baseline (undiluted)

0.9 % NaCl (dilution 1:16)

0.9 % NaCl (dilution 1:8)

3 % HTS (dilution 1:16)

3 % HTS (dilution 1:8)

20 % mannitol (dilution 1:16)

20 % mannitol (dilution 1:8)

PFA-100

       

 CtPFA (s)

60 (51–88)

73 (64–83)

72 (68–81)

77 (70–90)

108 (84–126)*,**

108 (89–132)*

172 (124–300)*,**,***

Ex-tem

       

 CT (s)

35 (28–55)

38 (36–60)

44 (31–62)

37 (33–83)

40 (34–48)

51 (38–99)*

90 (46–134)*,***

 CFT (s)

149 (131–159)

151 (128–184)

151 (123–175)

186 (148–206)

196 (176–249)*,**

204 (158–249)*

252 (222–314)*,**,***

 MCF (mm)

59 (55–62)

56 (50–60)

55 (53–57)

54 (51–57)

50 (46–53)*,**

53 (51–56)

49 (45–50)*,**

Fib-tem

       

 CT (s)

38 (30–43)

41 (33–51)

38 (32–47)

36 (32–42)

36 (32–43)

54 (28–66)

48 (38–58)

 MCF (mm)

8 (8–10)

7 (5–9)

7 (6–8)

7 (6–9)

7 (6–9)

7 (4–9)

5 (4–5)*,**,***

  1. Values are presented as median (interquartile range) *significant difference (P < 0.05) compared with baseline; **significant difference (P < 0.05) compared with 0.9 % saline at the same dilution; ***significant difference (P > 0.05) compared with 3 % HTS at the same dilution. Ct PFA closure time, CT clotting time, CFT clot formation time, HTS hypertonic saline, MCF maximum clot firmness